Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (16432)	11/14/2003 11:57:56 PM
From: aknahow	Read Replies (1) \| Respond to of 17367

I have no idea of why your post are not taking. I saw them in my e-mail which is rare as there is no monitoring of post. I will check and see what is going on.

To: Robert K. who wrote (16432)	11/18/2003 11:46:16 AM
From: Bluegreen	Respond to of 17367

Bob, can Raptiva cause a communication breakdown? How can a T cell act IF signal is not clear?????>>>>>>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14616784&dopt=Abstract

To: Robert K. who wrote (16432)	11/19/2003 12:24:59 PM
From: Bluegreen	Respond to of 17367

Bob, I posted that survey on Psoriasis in which it said over 80% surveyed had coverage that paid for meds. BTW who do you think pays for ALL THAT ENBREL for rheumatoid arthritis??? Sometimes I think people regard Raptiva as the only expensive medication out there. In fact it is one of MANY expensive medications out there........wasn't the first expensive medication and for sure won't be the last. Funny how these "expensive" medications are cheap when you take into account things like work productivity. I can't think of ONE corporation that would like "cheap" meds for their employees and then lose HUGE amounts of money through loss of productivity.

To: Robert K. who wrote (16432)	11/19/2003 1:28:30 PM
From: Bluegreen	Respond to of 17367

Here is the website for shipment news.......it is the European healthcare conference on the 18th>>>>>>>>>>>>>>>>>>>>>>>>>http://www.genentech.com/gene/index.jsp

To: Robert K. who wrote (16432)	11/22/2003 2:04:03 AM
From: Bluegreen	Read Replies (1) \| Respond to of 17367

Hey Bob, how many people with Psoriasis are in the gray zone of MILD to MODERATE???? Where is the line into MODERATE to get Raptiva?????? Won't patients be DEMANDING to be treated???? You have an excellent model when you look how Enbrel started out treating Rheumatoid arthritis..........and OH YEAH don't forget the mantra back then was Insurance wouldn't pay for such an expensive medication!!!!!! THEN WOW!!!!!!!!!!! All of a sudden HUGE demand for Enbrel which led to HUGE shortage!!!!! Will this debate turn into huge number of patients demanding these biologics for Psoriasis just like the model of Enbrel for rheumatoid arthritis??????